SCHEMBL15965637

SCHEMBL15965637

Oc1ccc(O)c(/C=N/N(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.66
EIF4H Q15056 1/20 0.66
MAPT P10636 4/20 0.54
GAA P10253 3/20 0.54
MAPK1 P28482 1/20 0.54
HTT P42858 1/20 0.54
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
AMY1A P0DUB6 1/20 0.47
LMNA P02545 2/20 0.47
HCRTR1 O43613 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
EGFR P00533 2/20 0.43
LCK P06239 1/20 0.43
USP2 O75604 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
PAX8 Q06710 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1132254 0.87 POLB (0.66) POLBEIF4HMAPTGAAMAPK1
SCHEMBL1132255 0.87 POLB (0.66) POLBEIF4HMAPTGAAMAPK1
SCHEMBL8416040 0.84 MAPT (0.65) POLBEIF4HMAPTGAAMAPK1
SCHEMBL8416037 0.84 MAPT (0.65) POLBEIF4HMAPTGAAMAPK1
SCHEMBL1132162 0.83 POLB (0.65) POLBEIF4HMAPTGAAMAPK1
SCHEMBL1132160 0.83 POLB (0.65) POLBEIF4HMAPTGAAMAPK1
SCHEMBL4668751 0.74 MAPT (0.74) POLBEIF4HMAPTGAAMAPK1
SCHEMBL4668750 0.74 MAPT (0.74) POLBEIF4HMAPTGAAMAPK1
SCHEMBL9427836 0.74 POLB (0.62) POLBEIF4HMAPTGAAMAPK1
SCHEMBL8416093 0.74 POLB (0.62) POLBEIF4HMAPTGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9447059-B2 Intermediate for manufacture of polymerizable compound and process for manufacture thereof ZEON CORPORATION (JP) 2016-09-20 US disclosed
US-9447059-B2 Intermediate for manufacture of polymerizable compound and process for manufacture thereof ZEON CORPORATION (JP) 2016-09-20 US disclosed
US-20140235857-A1 INTERMEDIATE FOR MANUFACTURE OF POLYMERIZABLE COMPOUND AND PROCESS FOR MANUFACTURE THEREOF ZEON CORPORATION (JP) 2014-08-21 US disclosed
US-20140235857-A1 INTERMEDIATE FOR MANUFACTURE OF POLYMERIZABLE COMPOUND AND PROCESS FOR MANUFACTURE THEREOF ZEON CORPORATION (JP) 2014-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140235857-A1 INTERMEDIATE FOR MANUFACTURE OF POLYMERIZABLE COMPOUND AND PROCESS FOR MANUFACTURE THEREOF COASY, CYBA, CYP1B1 POLB 3432/4885EIF4H 1133/4885MAPT 2005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.